S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
3 Free Stock Picks per Day (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
3 Free Stock Picks per Day (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
3 Free Stock Picks per Day (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
3 Free Stock Picks per Day (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
OTCMKTS:CVLBD

Conversion Labs (CVLBD) Stock Forecast, Price & News

$5.65
-0.09 (-1.57%)
(As of 11/10/2020)
Compare
Today's Range
$5.45
▼
$5.85
50-Day Range
$1.15
▼
$2.17
52-Week Range
$0.50
▼
$10.70
Volume
55,000 shs
Average Volume
80,256 shs
Market Capitalization
$93.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlinesShort Interest

CVLBD stock logo

About Conversion Labs (OTCMKTS:CVLBD) Stock

Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.

Receive CVLBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter.

CVLBD Stock News Headlines

March 29, 2023 | benzinga.com
NextEvo, Inc. Taps Coral Reef Labs on CBD Study: Most Brands 50% Off Label Claims
March 12, 2023 | sfgate.com
Best CBD Dog Treats in 2023: Top 5 New and Improved Treats for Healthy Tails
May 29, 2023 | Legacy Research (Affiliate) (Ad)
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
March 3, 2023 | dallasnews.com
Best CBD Gummies of 2023: 5 Tasty Products For Relaxation, Pain Relief, and More
March 3, 2023 | msn.com
SmartLabs to convert entire third floor of CambridgeSide mall into lab space
December 9, 2022 | benzinga.com
Green Scientific Labs announces the sale of New Jersey and Illinois assets
June 15, 2022 | bizjournals.com
Office-to-lab conversion trend comes to Boston's Back Bay
May 6, 2022 | bizjournals.com
Los Angeles is ‘busiest’ market for office-to-lab conversions
May 29, 2023 | UNKNOWN (Ad)
This NASDAQ Stock Is The Amazon Of Medical Supply
This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now
December 15, 2020 | finance.yahoo.com
Shareholders Are Raving About How The Conversion Labs (NASDAQ:CVLB) Share Price Increased 986%
December 15, 2020 | finance.yahoo.com
Conversion Labs Annualized Revenue Run-Rate Hits $53.9 Million, up 332% vs. 2019, Driven by Subscriptions to an Expanding Suite of Telehealth Brands
December 11, 2020 | finance.yahoo.com
Conversion Labs Launches Veritas MD™ Telehealth Platform, Delivering Greater Access to Growing Portfolio of Industry-Leading, Direct-to-Consumer Pharmacy and Wellness Brands
December 9, 2020 | finance.yahoo.com
Conversion Labs Approved for Nasdaq Capital Market Listing; Trading to Commence Tomorrow, December 10, 2020, Under the Symbol, CVLB
November 20, 2020 | finance.yahoo.com
Conversion Labs Appoints Expert Life Sciences Attorney, Eric H. Yecies, as Chief Compliance Officer and General Counsel
November 16, 2020 | finance.yahoo.com
Conversion Labs, Inc. to Host Earnings Call
October 26, 2020 | benzinga.com
How Conversion Labs Is Building Its Telemedicine Business During COVID-19
October 26, 2020 | finance.yahoo.com
Conversion Labs Licenses Restorsea Technology Platform for Launch of New Teledermatology Line, Nava MD™
See More Headlines
Receive CVLBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Miscellaneous Manufacturing Industries
Sub-Industry
N/A
Sector
Retail/Wholesale
Current Symbol
OTCMKTS:CVLBD
CUSIP
N/A
CIK
N/A
Web
www.conversionlabs.com
Phone
(866) 351-5907
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,140,000.00
Net Margins
-35.92%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-260.09%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.31
Quick Ratio
0.19

Sales & Book Value

Annual Sales
$12.47 million
Price / Sales
7.49
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.11) per share
Price / Book
-51.36

Miscellaneous

Outstanding Shares
16,533,000
Free Float
N/A
Market Cap
$93.41 million
Optionable
Not Optionable
Beta
1.21

Key Executives

  • Justin Schreiber
    Chairman, President & Chief Executive Officer
  • Stefan Galluppi
    Chief Operating & Technology Officer, Director
  • Juan Manuel Piñeiro Dagnery
    Chief Financial Officer & Controller
  • Joseph V. DiTrolio
    Director & Chief Medical Officer-US
  • Eric H. Yecies
    Chief Compliance Officer & General Counsel

Key Competitors

View All Competitors













CVLBD Stock - Frequently Asked Questions

How have CVLBD shares performed in 2023?

Conversion Labs' stock was trading at $1.94 at the beginning of the year. Since then, CVLBD shares have increased by 191.2% and is now trading at $5.65.
View the best growth stocks for 2023 here.

What is Conversion Labs' stock symbol?

Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLBD."

How do I buy shares of Conversion Labs?

Shares of CVLBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Conversion Labs' stock price today?

One share of CVLBD stock can currently be purchased for approximately $5.65.

How much money does Conversion Labs make?

Conversion Labs (OTCMKTS:CVLBD) has a market capitalization of $93.41 million and generates $12.47 million in revenue each year. The company earns $-3,140,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.conversionlabs.com. The company can be reached via phone at (866) 351-5907 or via email at info@conversionlabs.com.

This page (OTCMKTS:CVLBD) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -